The guinea pig migration inhibition technique, an accepted in vitro correlate of delayed hypersensitivity, has been adapted to a murine system. Peritoneal exudate cells from CF-1 mice vaccinated with viable cells of the H37Ra strain of Mycobacterium tuberculosis were inhibited in vitro by purified protein derivative (PPD) or whole H37Ra microorganisms. Peritoneal exudate cells from the inbred C57Bl/6 mice immunized with H37Ra cells also were inhibited in vitro by PPD or whole H37Ra microorganisms. Migration inhibitory factor (MIF) was produced by splenic lymphocytes from the H37Ra-immunized C57BI/6 mice when incubated with either antigen. Intravenous injection of PPD or viable H37Ra organisms into H37Ra mice resulted in MIF production in vitro by splenic lymphocytes without further antigenic stimulation. Peritoneal exudate cells from nonimmunized C57BI/6 mice and supernatant fluids from cultures of lymphocytes from nonimmunized C57Bl/6 mice were not inhibited in the presence of antigen. The production of MIF by splenic lymphoctyes from immunized C57BI/6 mice depended upon the conditions under which the lymphocytes were cultured, the time of exposure to antigen (3 days), the use of a higher concentration of PPD for stimulation of lymphocytes than that required for guinea pig cells, and also the use of cells from a highly inbred mouse strain.
The relationship between delayed hypersensitivity and cellular immunity to infection is still unresolved. Some investigators feel that acquired cellular immunity may merely be a manifestation of delayed hypersensitivity (11) . However, evidence is available which indicates that their concurrent appearance may be merely coincidental (13) .
In vitro techniques have become available which may be applied to the further study of this problem. The migration inhibition technique described. by George and Vaughan (9) and popularized by David and his co-workers (5, 6) has repeatedly been shown to be an effective in vitro correlate of delayed hypersensitivity. Inhibition of migration has been shown to be due to production of a soluble factor, called migration inhibitory factor (MIF), produced by sensitized lymphocytes when stimulated by antigen (2, 5) . were filled with the peritoneal cell suspension, sealed, and centrifuged at 200 x g for 10 min. The tubes were broken at the cell-fluid interface, and the cell-containing portions were placed in Mackaness-type chambers (10), with two tubes per chamber. Duplicate chambers were used for each test condition (four replicates in all). The filled chambers were incubated for 24 hr in a CO2 incubator at 37 C. The area of migration was determined by projection and planimetry.
In the direct test of migration inhibition, pooled peritoneal exudates were collected from at least 10 nonimmunized or immunized animals, and these cells were tested in chambers containing tissue culture medium either with or without antigen. The indirect assay to detect MIF production involved the addition of lymphocyte culture supernatant fluid to chambers containing macrophages from nonimmunized mice.
The migration of macrophages in medium without antigen in the direct test and in supernatant fluid from lymphocytes incubated without antigen in the indirect test was considered 100% migration. The effect of antigen in the medium or MIF in the lymphocyte culture supernatant fluid was determined by comparison with control: percent migration area of migration with antigen =~~~~~x 100
area of migration without antigen Results are reported as the mean percent migration of at least six replicate tests. The statistical significance of the differences between test and control conditions was determined by Student's t test on the pooled data.
Preparation of lymphocyte culture supernatant fluids. Spleens were collected from three or more nonimmunized or immunized mice in sterile NCTC 135 medium. Single cell suspensions were prepared by forcing the spleens through a sterile stainless-steel screen of 120 mesh. The pooled cells were centrifuged at 200 x g for 10 min and resuspended in cold NCTC 135. Total cell counts were made with a hemocytometer, and the cell concentration was adjusted to 1.5 x 107 cells/ml in the complete tissue culture medium. Amounts of 3 ml of suspension were placed in plastic tissue culture tubes and incubated at 37 C in a CO2 incubator. The spleen cells were cultured alone or in the presence of antigen or mitogen in the medium. After 1 to 3 days of incubation, the lymphocytes were sedimented by centrifugation. The supernatant fluids were then used to fill chambers containing peritoneal exudate cells from nonimmunized mice.
Spleens also were removed from nonimmunized or immunized mice which had received an intravenous injection of antigen 72 hr before sacrifice. Lymphocyte cultures were prepared from these cells as described above but without further antigenic stimulation in vitro.
RESULTS
Migration of peritoneal macrophages.
The procedures outlined in Materials and
Methods were those which ultimately were found to give the best results. In our initial studies, however, we had occasion to investigate a number of factors which appreciably affected the migration of mouse peritoneal exudate cells. From the data shown in Table 1 Table 3 shows that the peritoneal cells from H37Ra-immunized mice were significantly inhibited in their migration by 30 ,ug or more of PPD per ml; in contrast, regardless of concentration, PPD had no effect on the migration of cells from nonimmunized mice.
Effect of H37Ra cells. Viable H37Ra microorganisms were added to the medium in the migration chambers to determine the effect of whole bacilli on migration of peritoneal exudate cells. It was not feasible to use the outbred CF-1 mouse lymphocytes because all supernatant fluids were inhibitory, whether from immunized or nonimmunized, stimulated or nonstimulated animals. This probably was the result of a mixed lymphocyte reaction due to the pooling of lymphocytes from genetically different animals. Use of the inbred C57B1/6 strain mice allowed the successful production and detection of MIF as the result of specific stimulation of sensitized splenic lymphocytes.
It was possible to demonstrate that sensitivity to PPD or viable H37Ra microorganisms can be found only with spleen cells from H37Ra-immunized mice, and not with lymphocytes from nonimmunized animals. Detection of MIF production by sensitized murine lymphocytes in response to specific antigen was not limited to the tuberculin system. A similar specific reactivity in supernatant fluids from Listeria monocytogenes-immunized mice has been demonstrated (unpublished data).
Intravenous injection of antigen yielded spleen cell populations which produced supernatant fluids giving greater inhibition of migration than those produced by the same type of antigenic stimulation in vitro. Administration of antigen to the animal should encourage the proliferation of specifically sensitized cells in the spleen and should also result in more cells and more reactive cells in the splenic lymphocyte population. This greater number of sensitive cells would produce more MIF. Some of the antigen administered intravenously might remain in the spleen and subsequently stimulate the lymphocytes in vitro. However, the increased magnitude of activity could not be explained by this possibility alone. Intravenous administration of antigen also shows that MIF probably is produced in vivo and, therefore, strengthens the possibility that MIF plays a biological role in the intact animal.
An additional consequence of in vivo stimulation of sensitized animals has been the demonstration that delayed hypersensitivity as detected by dermal tests can be separated from the ability of lymphocytes to produce MIF in vitro (8). Collins and Mackaness (4) have stated that the absence of peripheral dermal hypersensitivity in desensitized animals cannot be used to argue against a relationship between delayed hypersensitivity and cellular immunity. Schlossman et al. (15) reported that guinea pigs injected intravenously with the sensitizing antigen gave negative skin tests, but their lymph node cells demonstrated antigeninduced incorporation of thymidine in vitro. Desensitization to dermal reactivity to tuberculin, therefore, may be due to the compartmentalization of reactive cells in the animal. Results presented here have shown that intravenous injection of antigen into sensitized animals resulted in both a decrease of footpad reactivity and an increase in MIF production by splenic lymphocytes. The production of MIF by lymphoctyes, therefore, appears to be a more sensitive measure of delayed hypersensitivity in the mouse than footpad reactivity.
The possibility that the inhibition of migration is caused by the presence of antigenantibody complexes rather than a specific lymphocyte product should be considered. The greatest inhibitory activity was seen after intravenous administration of antigen to sensitized animals. If antibody was involved, this stimulation should produce a secondary antibody response within 3 days. Spleen cell culture supernatant fluids from these animals should then produce immediate inhibitory activity due to the presence of the antibody combining with the large amount of antigen in the system. However, results presented here indicate that an additional 3 days in culture was required for the splenic lymphocytes to produce inhibitory activity. No additional antigen was added during this period. This strongly suggests that lymphocytes produce a specific factor during the culture period which is directly responsible for the inhibition of macrophage migration.
The development of a test which will detect the production of MIF by mouse lymphocytes will simplify the problem of the determination of the role of tuberculin hypersensitivity in immunity to tuberculosis. We have shown (12; C. L. Klun, R. G. Neiburger, and G. P. Youmans, in preparation) that lymphocytes from mice immunized with viable attenuated H37Ra cells, or ribonucleic acid isolated from these cells, when stimulated in vitro or in vivo with H37Ra cells, will produce a product which will bring about the inhibition of growth of virulent tubercle bacilli within macrophages in tissue culture. In a separate publication, we will show that this mycobacterial growth inhibiting factor appears to be a different lymphocyte product from the MIF described in the present publication.
